A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
What is the purpose of this trial?
The goal of the proposed pilot study is to determine whether glucose control can be improved with Bydureon treatment in patients with type I diabetes (T1D)
- 18 Years - 60 Years
- Juvenile Diabetes Research Foundation International
- Last Updated:
- Study HIC#: